Knoll Capital Management as of March 31, 2020
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 18 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Biohaven Pharmaceutical Holding | 27.4 | $29M | 858k | 34.03 | |
Corbus Pharmaceuticals Hldgs | 24.8 | $26M | 5.0M | 5.24 | |
Applied Therapeutics (APLT) | 19.7 | $21M | 642k | 32.69 | |
Abeona Therapeutics | 5.6 | $6.0M | 2.9M | 2.10 | |
Blackstone | 3.4 | $3.6M | 80k | 45.58 | |
Entera Bio (ENTX) | 3.1 | $3.3M | 1.7M | 1.88 | |
Eiger Biopharmaceuticals | 3.0 | $3.2M | 475k | 6.80 | |
Anavex Life Sciences (AVXL) | 2.1 | $2.3M | 724k | 3.15 | |
CenturyLink | 2.0 | $2.1M | 220k | 9.46 | |
Exicure | 1.8 | $1.9M | 1.3M | 1.48 | |
Molecular Templates | 1.4 | $1.5M | 114k | 13.29 | |
Aldeyra Therapeutics (ALDX) | 1.3 | $1.4M | 569k | 2.47 | |
Soligenix | 1.2 | $1.3M | 788k | 1.68 | |
Dow (DOW) | 0.8 | $877k | 30k | 29.23 | |
Corteva (CTVA) | 0.7 | $705k | 30k | 23.50 | |
Catasys | 0.6 | $655k | 43k | 15.22 | |
Dupont De Nemours (DD) | 0.5 | $512k | 15k | 34.13 | |
Bioxcel Therapeutics (BTAI) | 0.4 | $447k | 20k | 22.35 |